2018
DOI: 10.3324/haematol.2017.186338
|View full text |Cite
|
Sign up to set email alerts
|

Large granular lymphocyte cells and immune dysregulation diseases – the chicken or the egg?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 17 publications
0
9
0
Order By: Relevance
“…There have been many reported cases of T-LGL leukemia associated with underlying autoimmune disorders, malignancy, bone marrow failure, solid organ transplantation, or use of certain drugs. [2][3][4][5][6]13 In general, it is reported to be an indolent type of leukemia and the…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There have been many reported cases of T-LGL leukemia associated with underlying autoimmune disorders, malignancy, bone marrow failure, solid organ transplantation, or use of certain drugs. [2][3][4][5][6]13 In general, it is reported to be an indolent type of leukemia and the…”
Section: Discussionmentioning
confidence: 99%
“…Various T-LGL proliferations have been described in aplastic anemia, pure red cell aplasia, celiac disease, hypoplastic myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria, dasatinib therapy, lymphomas, solid organ recipients, and Felty syndrome. [2][3][4][5][6] The pathophysiology of clonal T-LGL proliferations is yet to be explained. The distinction between reactive and malignant entities is not well defined.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, IL-15 induces transcription of several anti-apoptotic proteins, such as Bcl-2, while increases proteasome-mediated degradation of pro-apoptotic factors, such as Bid, resulting in increased cell survival [ 35 ]. IL-15 also upregulates MYC , AURKA , and AURKB , responsible for centrosome alterations, and DNMT3B , ultimately leading to hypermethylation of tumor suppressor genes [ 36 , 37 ]. However, pathogenesis of LGL leukemia is not driven only by chronic antigen and proinflammatory cytokine stimulation, but also by constitutive activation of Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway and resistance to Fas/Fas-ligand (Fas-L)-mediated apoptosis [ 1 , 2 , 38 ].…”
Section: T-lgl Leukemia Pathogenesismentioning
confidence: 99%
“…12 However, firm conclusions regarding the precise impact of antigenic drive on T-LGL proliferations could not be drawn and, thus, it remains uncertain if T-LGL cells create an environment for 1 immune-dysregulation disorders to thrive or, instead, arise as a reactive population. 15 Here, we sought to obtain comprehensive insight into the TRB gene repertoire in a series of well-characterized patients with T-LGL lymphoproliferations employing next-generation sequencing (NGS), thus allowing not only to evaluate dominant clonotypes but also to unravel the subclonal architecture. Furthermore, by serial sampling over time and in different disease contexts, we aimed to elucidate if T-LGL lymphoproliferations emerge as reactive populations and how they evolve.…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, subcloning of individual TRBV‐TRBD‐TRBJ gene rearrangements followed by Sanger sequencing has also been performed, leading to low‐throughput and low‐resolution datasets 12 . However, firm conclusions regarding the precise impact of antigenic drive on T‐LGL proliferations could not be drawn and, thus, it remains uncertain if T‐LGL cells create an environment for immune‐dysregulation disorders to thrive or, instead, arise as a reactive population 15 …”
Section: Introductionmentioning
confidence: 99%